0Q15

Abbott Laboratories · LSE:0Q15

110.09 USD3.84 +3.61%

Abbott Laboratories (LSE:0Q15) last traded at 110.09 USD, up 3.61% on the day. Over the past year the stock is down 10.92%. Its 52-week range is 82.26 to 132.00. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open107.00

Day range105.00 – 110.24

52-week range82.26 – 132.00

Volume11.42 K

Average volume (10 days)13.72 K

Market cap183.77 B

P/E40.64

EPS (TTM)2.71

Dividend yield2.37%

Beta (1 year)0.9084

Revenue (TTM)48.23 B

Employees115.00 K

Performance

+6.88%1 week

+13.66%1 month

+3.72%3 months

+25.92%6 months

−12.34%Year to date

−10.92%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Abbott Touts Favorable Outcomes In Cardiovascular Device TrialsBenzinga · 02 Nov 2026
Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.